Regenerative medicines, the new era of human health, represent a wave of innovation coming to our health care system, approaching much faster than most realize. As of Q217, there were more than 822 companies developing regenerative medicine technologies.

New Orleans is a cultural destination, known for its exciting food, music and celebrations. While #AAOS2018 attendees may be missing Mardi Gras, there is still plenty to do and see. Even if you're worn out from a day at the convention, you can still experience a little bit of The Big Easy. Here are some of SmartTRAK's top ideas to get out and enjoy New Orleans!

SmartTRAK is excited to be attending AAOS 2018 - the American Academy of Orthopaedic Surgeons annual meeting, March 6-10 in New Orleans, LA. 

SmartTRAK will be hosting Ortho 2020: Joints, Biologics and Supply Chain Innovation, a panel reception, on Tuesday, March 6th, immediately following the Canaccord meeting at 4:30 in the Sheraton New Orleans Hotel, 500 Canal Street, New Orleans, LA, in the Lagniappe Room. Appetizers and cocktails will be provided and space is limited, so if you would like to attend, please RSVP by Feb 28, 2018.

Meet Kristina Meyer, SmartTRAK's Senior Analyst, Sports Medicine. Kristina has 12+ years' experience in marketing, field marketing and professional education, with a concentration on Sports Medicine, including Marketing and Sales Management roles at Smith & Nephew and Stryker Sports Medicine.

Kristina will be representing SmartTRAK at AANA18 , the Arthroscopy Assoc. of North America conference, April 26-28 in Chicago.

You can view Kristina's video below...

Taking on the orthopedic soft-tissue repair market with a novel, zip-tie inspired platform for knotless tissue repair and attachment

With the zip tie as inspiration, Sarasota, FL-based start-up Ziptek, LLC hopes to revolutionize the soft-tissue repair industry with a novel, self-locking, resorbable suture button for soft-tissue repair designed to facilitate natural tissue regeneration, strengthen the repair, and provide an alternative to knotless anchor devices in the US market for orthopedic soft tissue fixation, which is projected to reach over $1.8B by 2021E. 

BioMedGPS, a leader in real-time data and analysis in the life sciences industry, announced that Chris McCarthy has been elevated to the position of Vice President Corporate Accounts, SmartTRAK Orthopedics and Neuro, further filling out the BioMedGPS senior leadership team of life sciences industry veterans.

Meet Lisa Mahan, SmartTRAK's VP of Business Development, Orthopedics. Lisa has 20+ years of experience in the orthopedic industry, including 12 years at J&J DePuy Orthopaedics. View Lisa's video below...

SmartTRAK is excited to be attending #ISC 2018 - International Stroke Conference, January 24-26 at the Los Angeles Convention Center.

The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease.

Kas Amirdelfan, MD talked with SmartTRAK at the ASRA 2017 Annual Meeting regarding preliminary 12 month results from the SENZA-ULN study

Kas Amirdelfan, MD, principle investigator of the SENZA-Upper Limb and Neck (ULN) study, spoke with SmartTRAK's Anne Staylor at the recent American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting in Lake Buena Vista, FL regarding preliminary 12 month results from SENZA-ULN, the unmet clinical need for chronic intractable ULN pain, factors affecting physician adoption for this indication and what’s next for this research. (See ASRA Poster 4194.) 

A transcript of SmartTRAK’s interview with Dr. Amirdelfan is below or click on the following video to view the interview recorded live at ASRA 2017. (13:23 minutes.)

EWMA 2017, held in Amsterdam,  provided a unique and interesting look at the European Advanced Wound Care market - showcasing products approved for the European market but not yet launched in the US. Europe has always been a breeding ground for innovative medical devices, and has long served as a gateway for companies looking to bring new devices to the US. While some of these companies have no desire to enter the US market, many look to the US market with high expectations. It is the largest medical device market in the world, with one language and one regulatory and reimbursement system, and is much less complicated than the European market where distribution partnerships and regulatory approvals are sometimes needed for each country.

To read more about Advanced Wound Care growth for the US and EU and high tech advanced wound care products emerging from Europe that could be competing in the US market, please click to download the